[S2] シンポジウム2 小児神経領域におけるアンチセンス核酸とin vivo遺伝子治療の今までの展開と今後の課題

[S2-1] Exon skipping therapy for Duchenne muscular dystrophy:Its proposal 30 years ago, the present, and the future

^○Masafumi Matsuo (Graduate School of Science, Technology and Innovation, Kobe University, Kobe, Japan)

Password required to view